CO4230097A1 - Piridopirimidinas sustituidas como antihipertensivos - Google Patents
Piridopirimidinas sustituidas como antihipertensivosInfo
- Publication number
- CO4230097A1 CO4230097A1 CO94011315A CO94011315A CO4230097A1 CO 4230097 A1 CO4230097 A1 CO 4230097A1 CO 94011315 A CO94011315 A CO 94011315A CO 94011315 A CO94011315 A CO 94011315A CO 4230097 A1 CO4230097 A1 CO 4230097A1
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- hydroxy
- carboxi
- compound
- piridopirimidinas
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
REIVINDICACION NUMERO UN COMPUESTO DE FORMULA I FIGURA 1. EN DONDE n ES 0 A 3; R1 Y R2 SON, INDEPENDIENTEMENTE, H, ALQUILO C1-C6, HIDROXI (ALQUILO C1-C6), FORMILO, CARBONIL (ALQUI- LO C1-C6), CARBOXI, O CARBOXI (ALQUILO C1-C6); R3 Y R4 SON, INDEPENDIENTEMENTE, H, ALQUILO, C1-C6 O HIDROXI; R3 Y R4 SON H, O UNO ENTRE -CR3R3a Y -CR4R4a ES UN GRUPO CARBONILO; CON LA PREVISION DE QUE AL MENOS UNO DE LOS GRUPOS R1 Y R2 DEBE SER HIDROXI (ALQUI- LO C1-C6), FORMILO, CARBONIL, (ALQUILO C1-C6), CARBOXI O CARBOXI (ALQUILO C1-C6); O AL MENOS UNO ENTRE R3 Y R4 PUEDE SER HIDROXI; UNO ENTRE -CR3R3a y -CR4R4a DEBE SER UN GRUPO CARBONILO; Ar1 ES FIGURA 2 EN DONDE W ES H, ALQUILO C1-C6, HALOGENO, HIDROXI O ALCOXI C1-C6; Ar2 ES FIGURA 3 EN DONDE X ES FIGURA 4 EN DONDE R5 ES H, CH3, TER-BUTILO, TRI-n-BUTILES- TANNILO, O TRIFENILMETILO; O UN TAUTOMERO DE DICHO COMPUESTO O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE DICHO COMPUESTO O TAUTOMERO".
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3661593A | 1993-03-24 | 1993-03-24 | |
| US08/179,461 US5466692A (en) | 1993-03-24 | 1994-01-10 | Substituted pyridopyrimidines and antihypertensives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4230097A1 true CO4230097A1 (es) | 1995-10-19 |
Family
ID=21889617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO94011315A CO4230097A1 (es) | 1993-03-24 | 1994-03-22 | Piridopirimidinas sustituidas como antihipertensivos |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US5466692A (es) |
| KR (1) | KR100251822B1 (es) |
| BR (1) | BR1100834A (es) |
| CO (1) | CO4230097A1 (es) |
| TW (1) | TW321648B (es) |
| ZA (1) | ZA941897B (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5760220A (en) * | 1995-06-07 | 1998-06-02 | American Home Products Corporation | Process for preparation of biphenyl derivatives |
| JPH11507625A (ja) * | 1995-06-07 | 1999-07-06 | アメリカン・ホーム・プロダクツ・コーポレイション | ビフェニル誘導体の製造方法 |
| US7235551B2 (en) * | 2000-03-02 | 2007-06-26 | Smithkline Beecham Corporation | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| NZ524806A (en) * | 2000-10-23 | 2006-03-31 | Smithkline Beecham Corp | Tri-substituted 8H-pyrido[2,3-d]pyrimidin-7-one compounds |
| WO2002068419A1 (fr) * | 2001-02-26 | 2002-09-06 | Tanabe Seiyaku Co., Ltd. | Derive de pyridopyrimidine ou naphthyridine |
| RU2004133811A (ru) * | 2002-04-19 | 2005-04-20 | Смитклайн Бичам Корпорейшн (US) | Новые соединения |
| UY29440A1 (es) | 2005-03-25 | 2006-10-02 | Glaxo Group Ltd | Nuevos compuestos |
| JP2008535822A (ja) * | 2005-03-25 | 2008-09-04 | グラクソ グループ リミテッド | 新規化合物 |
| PE20061193A1 (es) * | 2005-03-25 | 2006-12-02 | Glaxo Group Ltd | DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2-[1H]-0NA COMO INHIBIDORES DE QUINASA p38 |
| WO2006104917A2 (en) * | 2005-03-25 | 2006-10-05 | Glaxo Group Limited | Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1h)-one derivatives |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
| US11066404B2 (en) | 2018-10-11 | 2021-07-20 | Incyte Corporation | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors |
| US11384083B2 (en) | 2019-02-15 | 2022-07-12 | Incyte Corporation | Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors |
| WO2020180959A1 (en) | 2019-03-05 | 2020-09-10 | Incyte Corporation | Pyrazolyl pyrimidinylamine compounds as cdk2 inhibitors |
| WO2020205560A1 (en) | 2019-03-29 | 2020-10-08 | Incyte Corporation | Sulfonylamide compounds as cdk2 inhibitors |
| WO2020223558A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | Tricyclic amine compounds as cdk2 inhibitors |
| US11440914B2 (en) | 2019-05-01 | 2022-09-13 | Incyte Corporation | Tricyclic amine compounds as CDK2 inhibitors |
| KR20220064369A (ko) | 2019-08-14 | 2022-05-18 | 인사이트 코포레이션 | Cdk2 저해제로서의 이미다졸릴 피리디미딘일아민 화합물 |
| WO2021072232A1 (en) | 2019-10-11 | 2021-04-15 | Incyte Corporation | Bicyclic amines as cdk2 inhibitors |
| US11981671B2 (en) | 2021-06-21 | 2024-05-14 | Incyte Corporation | Bicyclic pyrazolyl amines as CDK2 inhibitors |
| US11976073B2 (en) | 2021-12-10 | 2024-05-07 | Incyte Corporation | Bicyclic amines as CDK2 inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0481614A1 (en) * | 1990-10-01 | 1992-04-22 | Merck & Co. Inc. | Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists |
| IL100917A0 (en) * | 1991-02-16 | 1992-11-15 | Fisons Plc | Pyridinone and pyrimidinone derivatives,their preparation and pharmaceutical compositions containing them |
| IL101860A0 (en) * | 1991-05-31 | 1992-12-30 | Ici Plc | Heterocyclic derivatives |
| US5149699A (en) * | 1991-10-24 | 1992-09-22 | American Home Products Corporation | Substituted pyridopyrimidines useful as antgiotensin II antagonists |
| US5296480A (en) * | 1993-04-23 | 1994-03-22 | American Cyanamid Company | Angiotensin II receptor blocking 2,3,6-substituted 5,6,7,8-tetra-hydro-pyrido[4,3]pyrimidin-4(3H)-ones |
| US5281602A (en) * | 1993-04-23 | 1994-01-25 | American Cyanamid Company | Angiotensin II receptor blocking 2,3,6-substituted 5,6,7,8-tetrahydro-pyrido[4,3-D]pyrimidin-4(3H)-ones |
-
1994
- 1994-01-10 US US08/179,461 patent/US5466692A/en not_active Expired - Lifetime
- 1994-03-16 TW TW083102290A patent/TW321648B/zh active
- 1994-03-17 ZA ZA941897A patent/ZA941897B/xx unknown
- 1994-03-22 KR KR1019940005683A patent/KR100251822B1/ko not_active IP Right Cessation
- 1994-03-22 CO CO94011315A patent/CO4230097A1/es unknown
-
1997
- 1997-05-12 BR BR1100834-2A patent/BR1100834A/pt active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ZA941897B (en) | 1995-09-18 |
| US5466692A (en) | 1995-11-14 |
| KR940021553A (ko) | 1994-10-19 |
| TW321648B (es) | 1997-12-01 |
| BR1100834A (pt) | 2000-06-06 |
| KR100251822B1 (ko) | 2000-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4230097A1 (es) | Piridopirimidinas sustituidas como antihipertensivos | |
| TW271395B (es) | ||
| SE8503680L (sv) | Indolderivat | |
| TR199700844T1 (xx) | Pirazolil-Benzoil T�revleri. | |
| YU35697A (en) | Substituted 6,6-hetero-bicyclic derivatives | |
| ES8206440A1 (es) | Un procedimiento para la preparacion del enantiomero (-) de la n-metil-3-(2metilfenoxi)-3-fenilpropilamina. | |
| NZ325449A (en) | Naphthyl-substituted benzimidazole derivatives as anticoagulants | |
| MX9701538A (es) | Sales de un derivado del indol contra la migraña. | |
| FI862757A (fi) | Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa. | |
| ATE206708T1 (de) | Benzimidazolonderivate mit zentraler dopaminerger aktivität | |
| DE3873007D1 (de) | Kathartica. | |
| TR199801000T2 (xx) | Bile�ikler | |
| DE69530988T2 (de) | Benzimidazolderivate mit dopaminerger wirkung | |
| ATE130603T1 (de) | Oxalon und hypotensive 2-decarboxyl-2 azylthioalkyl prostagladin-derivate. | |
| CO5011066A1 (es) | Compuestos de triazina | |
| ES8405779A1 (es) | Un procedimiento para preparar derivados de 1-fenoxi-3-(4-fenilpiperazino)-2-propanol. | |
| ITMI920084A1 (it) | Alchil derivati del trazodone | |
| ES2150564T3 (es) | Proceso para la preparacion de derivados de 5,6-dihidroxi-2-amino-1,2,3,4-tetrahidronaftaleno. | |
| GR1001309B (el) | Μεθοδος παρασκευης παραγωγου ενωσεως της διχλωροανιλινης. | |
| HK1067948A1 (en) | Antitumor indolopyprolocarbazole derivative | |
| ECSP951499A (es) | Compuestos ariltios |